Botox 200 unit vials

Ended Awarded

Contract number
SPE2DB24FY18X
Awardee
Awarding agency
Obligated
$15,524

Award facts

Contract value 100% obligated
$15,524.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4,562,472,907 units of BOTOX 200 unit vials. The contract, which has an ultimate completion date of November 3, 2023, has a ceiling value of $15,524.40. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB22D9362 with DLA, which allows the agency to order a broad range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DB24FY18X?

SPE2DB24FY18X was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 13, 2023.

How much is contract SPE2DB24FY18X worth?

The government has obligated $15,524 on SPE2DB24FY18X.

Is contract SPE2DB24FY18X an order under another contract?

Yes. SPE2DB24FY18X is a delivery order under SPE2DB22D9362, an indefinite delivery contract.

Was contract SPE2DB24FY18X competed?

The extent of competition for SPE2DB24FY18X was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award